Notably, presenilin 1 (PSEN1) is linked to early-onset AD (EOAD) (Bagaria et al., 2022) (Figure 1), which is characterized by mutations in APP, PSEN1, or presenilin 2 (PSEN2). Here, PSEN2 is linked to Alzheimer disease.